Key result
Global early-onset ASCVD prevalence increased slightly since 1990, with heavier burden in men and low-SDI countries.
Why the study?
Early-onset atherosclerotic cardiovascular diseases impose a significant burden on individuals, families, and society, but global, regional, and national burden trends remained to be evaluated.
Observational
Yes
The global burden of early-onset ASCVD remains high and is increasing, particularly in men and lower sociodemographic index regions, driven by modifiable risk factors like dietary risks, high LDL, and high systolic blood pressure.
Answers are grounded in this paper and cite their sources.
Slight global rise in early-onset ASCVD prevalence, concentrated in low-SDI regions and men, warrants targeted risk-factor monitoring; leaves open causal drivers and prevention efficacy.
Background Early-onset atherosclerotic cardiovascular diseases (ASCVD) impose a significant burden on individuals, families, and society. This study aimed to evaluate the burden of early-onset ASCVD at the global, regional, and national levels from 1990 to 2021. Methods The data for this study were sourced from the Global Burden of Disease (GBD) 2021 study. The study focused on early-onset ASCVD-related diseases (15 - 55 years) and downloaded specific data for analysis. Joinpoint regression analysis was performed to explore temporal trends in prevalence, incidence, mortality, and disability-adjusted life years (DALYs) of early-onset ASCVD. The inequality slope index and concentration index were used to measure the inequality in the distribution of the disease burden across countries. Decomposition analysis was conducted to identify the factors influencing the changes in the disease burden. The Bayesian age-period-cohort analysis model was used to predict future trends. This study also examined the impact of specific risk factors on early-onset ASCVD burden. Results In 2021, the global number of early-onset ASCVD cases increased significantly, and the age-standardized prevalence rate (ASPR) demonstrated a slight increase from 1547.3 per 100,000 persons (95% UI: 1270.4-1869.3) in 1990 to 1551.5 per 100,000 persons (95% UI: 1250.5-1906.1) in 2021. The age-standardized incidence, mortality, and disability-adjusted life years (DALYs) varied across regions and countries and were associated with the Socio-demographic Index (SDI). The age-standardized incidence and prevalence rates were higher in men than in women. Inequality analysis showed that the burden was heavier in low-SDI regions. Decomposition analysis indicated that population growth and aging contributed to the increase in the disease burden, while epidemiological changes helped reduce it. Future predictions suggest that the global burden will remain relatively stable but with different trends. Dietary risks, high LDL cholesterol, and high systolic blood pressure were the main the attributable risk factors for death and DALYs. Conclusion Early-onset ASCVD is a serious global health issue, especially in men and countries with low medium sociodemographic index. Since the attributable risk factors of early-onset ASCVD are modifiable, specific measures need to be taken in countries with different levels of socioeconomic development.
No takes yet. Share an insight, caveat, or question.
Du et al. (2025) conducted an observational in Early-onset atherosclerotic cardiovascular diseases (ASCVD). Time period (2021) vs. 1990 was evaluated on Age-standardized prevalence rate (ASPR) per 100,000 persons. The global age-standardized prevalence rate of early-onset ASCVD increased slightly from 1547.3 per 100,000 persons in 1990 to 1551.5 per 100,000 persons in 2021.
Synapse has enriched 10 related papers. Consider them for comparative context: